CardioTomLuscher (@tomluscher) 's Twitter Profile
CardioTomLuscher

@tomluscher

Cardiologist. Author. Innovator. My topic: Frontiers in Cardiovascular Disease

ID: 941253473051529216

linkhttp://www.insidecardiology.ch calendar_today14-12-2017 10:28:10

644 Tweet

5,5K Followers

131 Following

CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

The 7th Kosovo Congress on Cardiology in Pristina last week: A great meeting with a young National Cardiac Society of the ESC on the move with fanastic lectures by the internatinal and national faculty - great education and warm friendship - many thnaks for having us!

The 7th Kosovo Congress on Cardiology in Pristina last week: A great meeting with a young National Cardiac Society of the ESC on the move with fanastic lectures by the internatinal and national faculty - great education and warm friendship - many thnaks for having us!
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Obesity is the top medical issue of our time: Watch what solutions there are from John Deanfiled in his lecture of the pharmacological options today and tomorrow at vimeopro.com/zurichhearthou… or the zhh Website:  zhh.ch/en/elearning/o…

Obesity is the top medical issue of our time: Watch what solutions there are from John Deanfiled in his lecture of the pharmacological options today and tomorrow at vimeopro.com/zurichhearthou…
or the zhh Website:  zhh.ch/en/elearning/o…
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Congratulations to Florian Wenzl for winning the Research Prize of the Swiss Society of Cardiology in Lausanne this month for his seminal work on Dipeptityl Peptidas-3 in acute coronar syndromes and cardiagenic shock - a discovery that might lead to a trial with a blocking AB.

Congratulations to Florian Wenzl for winning the Research Prize of the Swiss Society of Cardiology in Lausanne this month for his seminal work on Dipeptityl Peptidas-3 in acute coronar syndromes and cardiagenic shock - a discovery that  might lead to a trial with a blocking AB.
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Congratulations to Kangmin Yang for the Best Papper 2023 Award of the Swiss Society of Hypertension! A great study on Sirt1 and endothelial function and oxidative stress. Another great achievement of a fellow of the Center for Molecualr Cardiology - we are proud of our scientists

Congratulations to Kangmin Yang for the Best Papper 2023 Award of the Swiss Society of Hypertension! A great study on Sirt1 and endothelial function and oxidative stress. Another great achievement of a fellow of the Center for Molecualr Cardiology - we are proud of our scientists
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

30 Years of Zurich Heart House: The Foundation for CV Research celebrates its success with alumni at the lake of Zurich in splendid weather ! 153 research fellows have been supported, 33 later became professors, 8 Assistent Professors financed at the UZH - a fantastic legacy!

30 Years of Zurich Heart House: The Foundation for CV Research celebrates  its success with  alumni at the lake of Zurich in  splendid weather ! 153 research fellows have been supported, 33 later became professors, 8 Assistent Professors financed at the UZH - a fantastic legacy!
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

What matters fater 30 years of research? The feloows and their profesional development one can provide. the ZHH di well on that and we are proid of it! 153 fellows and out of them 33 professors in different specialties in 11 countries - we will continue in that legacy!

What matters fater 30 years of research? The feloows and their profesional development one can provide. the ZHH di well on that and we are proid of it! 153 fellows and out of them 33 professors in different specialties in 11 countries - we will continue in that legacy!
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

At a loss on how to manage cardiac sarcoidosis? Have a look at this Consensus Statement of the ESC Associations on how to assess, diagnose and manage these patients in an interdisciplinary MDT - it is free at academic.oup.com/eurheartj/adva…

At a loss on how to manage cardiac sarcoidosis? Have a look at this Consensus Statement of the ESC Associations on how to assess, diagnose and manage these patients in an interdisciplinary MDT - it is free at academic.oup.com/eurheartj/adva…
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Cardiogenic Shock is the frontier in ACS: We are getting there, but need a paradigm shift from pure mechanical to a combined biological and interventional approach - cardiometabolic unloading of the left ventricule appears to road to success - see academic.oup.com/eurheartj/adva…

Cardiogenic Shock is the frontier in ACS: We are getting there, but need a paradigm shift from pure mechanical to a combined biological and interventional approach - cardiometabolic unloading of the left ventricule appears to road to success - see academic.oup.com/eurheartj/adva…
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Save the date for Aortic Dissection (AD) on September 6th in London: AD remains a severe condition with excessive mortality. Thus, to detect and manage it promtly and professionally is crucial - get state-of the-art of AD at aorticdissectionsymposium.com

Save the date for Aortic Dissection (AD) on September 6th in London: AD remains a severe condition with excessive mortality. Thus, to detect and manage it promtly and professionally is crucial - get state-of the-art of AD at aorticdissectionsymposium.com
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Are Glycoprotein IIB/IIIA still center stage in ACS undergiong PCI? Potent P2 Y12 inhibitors reduce the risk of MACE,but increase risk of major bleedings at 1 year. GPI i might be considered in selected patients with high ischaemic and low bleeding risks.

Are Glycoprotein IIB/IIIA still center stage in ACS undergiong PCI?  Potent P2 Y12 inhibitors reduce the risk of MACE,but  increase risk of major bleedings at 1 year.  GPI i might be considered in selected patients with high ischaemic and low bleeding risks.
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

2 weeks to go to catch the 4th edition of the PCHF London: A fantastic course with an outstanding faculty, lectures, rapid fire and hands-on sessions on imaging, interventions and devices. Don't miss it an go for it at heartfailurecourse.uk before Aug. 31st

2 weeks to go to catch the 4th edition of the PCHF London: A fantastic course with an outstanding faculty, lectures, rapid fire and hands-on sessions on imaging, interventions and devices. Don't miss it an go for it at heartfailurecourse.uk before Aug. 31st
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Artificial Intelligence and machine learning will chance cardiology more than what we saw for many years. Algorithms make deiagnosis and management faster reproducilbe and more precise. Quality standards are essentiel for their routine use. Get complete insught into AI and CVD

Artificial Intelligence and machine learning will chance cardiology more than what we saw  for many years. Algorithms  make deiagnosis and management faster  reproducilbe and more precise. Quality standards are essentiel for their routine use. Get complete insught into AI and CVD
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

The Center for Molecular Cardiology is proud to host rising stars in cardiology and CV research - both at the basic and clinical level. Vidya in cardiometabolic conditions and Florian on novel biomarkers and clinical outcomes in CAD and shock. Watch the promising young colleagues

The Center for Molecular Cardiology is proud to host rising stars in cardiology and CV research - both at the basic and clinical level. Vidya in cardiometabolic conditions and Florian on novel biomarkers and clinical outcomes in CAD and shock. Watch the promising young colleagues
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

One week to go! Don't miss August 31st for the 4th Edition of the Postgraduate Course in Heart Failure London, a 6 module programme over 2 years with an outstanding faculty, lectures, cases, simulators and device programming - become an expert in HF at heartfailurecourse.uk

One week to go! Don't miss August 31st  for the 4th Edition of the Postgraduate Course in Heart Failure London, a  6 module programme over 2 years with an outstanding faculty, lectures, cases, simulators and device programming - become an expert in HF at heartfailurecourse.uk
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Here ist the link for applications for the Postgraduate Course on Heart Failure London with deadline of Augst 31st, 2024 1. heartfailurecourse.uk

Here ist the link for applications for the Postgraduate Course on Heart Failure London with deadline of Augst 31st, 2024 1. heartfailurecourse.uk
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

ESC London 2024: A fantastic congress with 26'500 participants on site and 5'000 online from over 80 countires, a record of 12 Hotline Sessions, great presentations and a change in guard to a new ESc Board with outstanding officers. The ESC goes global, the prime congress on CVM

ESC London 2024: A fantastic congress with 26'500 participants on site and 5'000 online from over 80 countires, a record of 12 Hotline Sessions, great presentations and a change in guard to a new ESc Board with outstanding officers. The ESC goes global, the prime congress on CVM
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

After the ESC 2024 is before the ESC Update of the Zurich Heart House: Get a comprehensive insight into all the new ESC Guidelines by those who chaired it - it will be important for your daily practice. Here is the link: zhh.ch/en/agenda/esc-…

After the ESC 2024 is before the ESC Update of the Zurich Heart House: Get a comprehensive insight into all the new ESC Guidelines by those who chaired it - it will be important for your daily practice. Here is the link: zhh.ch/en/agenda/esc-…
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

The dream team of the Center for Molecular Cardiology ist on the move: With the Royal Brompton Hospital and Imperial College London and Leicester University they had 24 presentation, incl. 2 Late Breakers, 2 lectures, 2 simultaneously published FAST TRACKs in the EHJ: Congrats!

The dream team of the Center for Molecular Cardiology ist on the move: With the Royal Brompton Hospital and Imperial College London and Leicester University they had 24 presentation, incl. 2 Late Breakers, 2 lectures, 2 simultaneously published FAST TRACKs in the EHJ: Congrats!
CardioTomLuscher (@tomluscher) 's Twitter Profile Photo

Missed the ESC Guidelines Update of the ZHH? No worries, it has been streamed to provide you with a crisp and practical summary of the essentiels of hypertension, chronic coronary syndromes, atrial fibirllation and Aorta/PAD. at vimeopro.com/zurichhearthou…

Missed the ESC Guidelines Update of the ZHH? No worries, it has been streamed to provide you with a crisp and practical summary of the essentiels of hypertension, chronic coronary syndromes, atrial fibirllation and Aorta/PAD. at vimeopro.com/zurichhearthou…